Literature DB >> 28013363

Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy.

Shijing Qiu1, George W Divine2, Saroj Palnitkar3, Pooja Kulkarni3, Trent S Guthrie4, Mahalakshmi Honasoge5, Sudhaker D Rao3,5.   

Abstract

Atypical femur fracture (AFF), a serious complication of long-term bisphosphonate therapy, is usually preceded by an incomplete fracture appearing on the lateral femur. AFF is most likely the result of severely suppressed bone turnover (SSBT). However, the differences in bone structure and turnover between patients with incomplete and complete AFF remain unknown. We examined trans-iliac bone biopsies from 12 white postmenopausal women with AFF (incomplete = 5; complete = 7) on BP therapy of >5 years and 43 healthy white premenopausal women. Histomorphometric measurements were performed separately in cancellous, intracortical and endosteal envelopes. Of the 43 histomorphometric measurements on 3 difference bone surfaces (cancellous, intracortical and endosteal), only 2 bone resorption variables (Oc.S/BS and Oc.S/NOS) on the endosteal surface were significantly lower in patients with complete AFF than those with incomplete AFF. Compared to healthy premenopausal women, the trabecular bone volume, thickness and number were all significantly lower in patients with AFF. The dynamic bone formation variables in patients with AFF were significantly reduced on all bone surfaces. The likelihood of a biopsy with no tetracycline labeling was significantly higher in AFF patients than in healthy premenopausal women. Based on these results, we conclude that there are no significant differences in bone turnover between patients with incomplete and complete AFF, suggesting that the suppression of bone turnover had already existed in the femur with incomplete AFF. Compared to healthy premenopausal women, bone turnover is similarly suppressed in patients with either type of AFF.

Entities:  

Keywords:  Atypical femur fracture; Bisphosphonates; Iliac bone biopsy; Prodromal bone deterioration; Severely suppressed bone turnover

Mesh:

Substances:

Year:  2016        PMID: 28013363      PMCID: PMC5315598          DOI: 10.1007/s00223-016-0223-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  41 in total

1.  Effect of ethnicity and age or menopause on the structure and geometry of iliac bone.

Authors:  Z H Han; S Palnitkar; D S Rao; D Nelson; A M Parfitt
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

2.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

3.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

4.  Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.

Authors:  Renata La Rocca Vieira; Zehava Sadka Rosenberg; Mary B Allison; Shelly A Im; James Babb; Valerie Peck
Journal:  AJR Am J Roentgenol       Date:  2012-05       Impact factor: 3.959

Review 5.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

6.  Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

Authors:  Robert Recker; Joan Lappe; K Michael Davies; Robert Heaney
Journal:  J Bone Miner Res       Date:  2004-07-21       Impact factor: 6.741

7.  Incidence and bone biopsy findings of atypical femoral fractures.

Authors:  Inari S Tamminen; Tero Yli-Kyyny; Hanna Isaksson; Mikael J Turunen; Xiaoyu Tong; Jukka S Jurvelin; Heikki Kröger
Journal:  J Bone Miner Metab       Date:  2013-04-04       Impact factor: 2.626

8.  Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.

Authors:  Reina Armamento-Villareal; Nicola Napoli; Kathryn Diemer; Marcus Watkins; Roberto Civitelli; Steven Teitelbaum; Deborah Novack
Journal:  Calcif Tissue Int       Date:  2009-06-23       Impact factor: 4.333

9.  Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.

Authors:  R R Recker; L-G Ste-Marie; P Chavassieux; M R McClung; M W Lundy
Journal:  Osteoporos Int       Date:  2014-10-11       Impact factor: 4.507

10.  Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility.

Authors:  Matthijs P Somford; Frits W Draijer; Bregje J W Thomassen; Pascale M Chavassieux; Georges Boivin; Socrates E Papapoulos
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

View more
  5 in total

1.  Reference Intervals for Bone Histomorphometric Measurements Based on Data from Healthy Premenopausal Women.

Authors:  Shijing Qiu; George Divine; Elizabeth Warner; Sudhaker D Rao
Journal:  Calcif Tissue Int       Date:  2020-08-20       Impact factor: 4.333

2.  Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.

Authors:  Tingjun Ye; Peng Cao; Jin Qi; Qi Zhou; D Sudhaker Rao; Shijing Qiu
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

3.  Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance.

Authors:  Cheng-Hui Ke; Hong-Yun Li; Dan Yang; Hao Ying; Jun Xu; Jian Wang; Hong-Wen Zhu; Lin Wang
Journal:  Orthop Surg       Date:  2021-10-21       Impact factor: 2.071

4.  Bone adaptation in response to treadmill exercise in young and adult mice.

Authors:  Joseph D Gardinier; Niloufar Rostami; Lauren Juliano; Chunbin Zhang
Journal:  Bone Rep       Date:  2018-01-12

5.  Teriparatide Improves Bone and Lipid Metabolism in a Male Rat Model of Type 2 Diabetes Mellitus.

Authors:  Sachiko Nomura; Akihiro Kitami; Ryoko Takao-Kawabata; Aya Takakura; Momoko Nakatsugawa; Ryohei Kono; Akihiro Maeno; Akihiko Tokuda; Yukihiro Isogai; Toshinori Ishizuya; Hirotoshi Utsunomiya; Misa Nakamura
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.